Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Application of long noncoding ribonucleic acid nonratt021972 small interfering ribonucleic acid in the preparation of drugs for diabetes complicated with neuropathic pain

A technology of NONRATT021972, neuropathic pain, applied in the direction of nervous system diseases, drug combination, non-central analgesics, etc., can solve the problem that there are not many studies on long non-coding RNA

Active Publication Date: 2018-12-04
NANCHANG UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, breakthroughs have been made in the research of non-coding RNAs (such as microRNA, siRNA and piRNA) with a length of less than 50 nucleotides, but there are not many studies on functional long non-coding RNAs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of long noncoding ribonucleic acid nonratt021972 small interfering ribonucleic acid in the preparation of drugs for diabetes complicated with neuropathic pain
  • Application of long noncoding ribonucleic acid nonratt021972 small interfering ribonucleic acid in the preparation of drugs for diabetes complicated with neuropathic pain
  • Application of long noncoding ribonucleic acid nonratt021972 small interfering ribonucleic acid in the preparation of drugs for diabetes complicated with neuropathic pain

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] The oral or injectable long noncoding ribonucleic acid NONRATT021972 small interfering RNA preparation suitable for the treatment of diabetic neuropathic pain was prepared by methods known in the art.

Embodiment 2

[0025] The oral or injectable long non-coding ribonucleic acid NONRATT021972 small interfering RNA preparation suitable for the treatment of diseases related to diabetes complicated with nerve injury was prepared by methods known in the art.

Embodiment 3

[0027] The oral or injectable long noncoding ribonucleic acid NONRATT021972 small interfering RNA preparation suitable for the treatment of diabetes complicated with sensory neuroinflammation-related diseases is prepared by methods known in the art.

[0028] In a word, long non-coding ribonucleic acid NONRATT021972 small interfering ribonucleic acid can be used for oral administration, injection, buccal tablet or other local or systemic dosage forms to prevent and treat the above diseases.

[0029] In order to better understand the essence of the present invention, the following long non-coding ribonucleic acid NONRATT021972 small interfering ribonucleic acid pair P2X 3 Experiments and results of receptor-mediated treatment of related diseases to prove the use of long non-coding ribonucleic acid NONRATT021972 small interfering ribonucleic acid.

[0030] 1. Materials and methods.

[0031] 1. Animals and grouping.

[0032] Healthy Sprague-Dawley (SD) rats were provided by the ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a use of a long non-coding ribonucleic acid NONRATT021972 small interfering RNA in preparation of a drug for treating diabetes mellitus with neuropathic pain. An experiment proves that the NONRATT021972 small interfering RNA can reduce dorsal root ganglion neuron P2X3 receptor expression, reduce diabetic rat serum cell inflammatory factor-tumor necrosis factor content, improve diabetic rat serum catalase and superoxide dismutase activity, inhibit dorsal root ganglion noxious information transmission, reduce nerve injury and inflammatory material damage stimulation, reduce diabetes mellitus type 2 rat neuropathic pain and be used for preparation of drugs for treating diabetes mellitus with neuropathic pain, diabetes mellitus with nerve injury related diseases, and diabetes mellitus with sensory nerve inflammatory diseases.

Description

technical field [0001] The present invention relates to the invention field of the drug application of diabetes complicated with neuropathic pain. Background technique [0002] Diabetes Mellitus (DM) is a group of metabolic clinical syndromes. With the development of society and the improvement of people's living standards, the prevalence of diabetes is increasing year by year. In developed countries, the prevalence of diabetes has reached 3%-7%. , has become the fourth priority disease after cancer, AIDS, and cardiovascular and cerebrovascular diseases, and has become the fifth leading cause of death in the world. Diabetes is divided into type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes. It is estimated that one in six people worldwide is at risk of complications from diabetes. Type 2 diabetes accounts for more than 90% of the diabetic population in my country, which seriously affects people's health and social development. Diabetic neuropathy is on...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K48/00A61K31/7088A61P3/10A61P25/02A61P29/00
Inventor 梁尚栋彭海英李桂林刘双梅徐宏高云虞诗诚樊波
Owner NANCHANG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com